Home > Insider Trading > Filing (0001127602-23-014615)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1333760	S Karen Lynch	One Cvs Drive Woonsocket RI 02895	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock (By Trust)	Acquisiton	2023-05-03	14,000	$69.75	431,392	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Appreciation Rights	$45.91	2019-02-17	2027-02-16	192,741	192,741	Direct
Common Stock	Stock Appreciation Rights	$37.91	2019-02-19	2026-02-18	93,989	93,989	Direct
Common Stock	Stock Option	$54.19	2020-04-01	2029-04-01	242,408	242,408	Direct
Common Stock	Stock Option	$58.34	2021-04-01	2030-04-01	211,196	211,196	Direct
Common Stock	Stock Option	$74.30	2022-04-01	2031-04-01	224,604	224,604	Direct
Common Stock	Stock Option	$101.09	2023-04-01	2032-04-01	171,517	171,517	Direct
Common Stock	Stock Option	$74.31	2024-04-01	2033-04-01	244,952	244,952	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2027-02-16	192,741	192,741	Direct
2026-02-18	93,989	93,989	Direct
2029-04-01	242,408	242,408	Direct
2030-04-01	211,196	211,196	Direct
2031-04-01	224,604	224,604	Direct
2032-04-01	171,517	171,517	Direct
2033-04-01	244,952	244,952	Direct

Footnotes

Represents unvested Aetna Inc. Stock Appreciation Rights ("SARs") granted under the Aetna Plan on February 17, 2017 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vest in two substantially equal annual installments beginning on February 17, 2019.
Represents unvested SARs granted under the Aetna Plan on February 19, 2016 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested on February 19, 2019.
Option became exercisable in four equal annual installments, commencing 4/1/2020.
The number of shares subject to the option were calculated using a 30-day average price.
Option became exercisable in four equal installments, commencing 4/1/2021.
Option became exercisable in four equal installments, commencing 4/1/2022.
Option became exercisable in four equal installments, commencing 4/1/2023.
Option becomes exercisable in four equal annual installments, commencing 4/1/2024.